Treatment of botulinum toxin-induced eyelid ptosis with anticholinesterases.
Karami
Mojtaba
M
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. mojtabakaramid@yahoo.com
Taheri
Arash
A
Mansoori
Parisa
P
D001763:Blepharoptosis / Q000139:chemically induced* / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D011729:Pyridostigmine Bromide / Q000008:administration & dosage*; D015595:Skin Aging / Q000187:drug effects
D002800:Cholinesterase Inhibitors; D019274:Botulinum Toxins, Type A; D011729:Pyridostigmine Bromide